April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Quantitative Fundus Autofluorescence in Bull’s-Eye Maculopathy
Author Affiliations & Notes
  • Tobias Duncker
    Ophthalmology, Columbia University, New York, NY
  • Francois C Delori
    Schepens Eye Research Institute, Boston, MA
  • Jonathan P Greenberg
    Ophthalmology, Columbia University, New York, NY
  • Winston Lee
    Ophthalmology, Columbia University, New York, NY
  • Jana Zernant
    Ophthalmology, Columbia University, New York, NY
  • Rando Allikmets
    Ophthalmology, Columbia University, New York, NY
  • Stephen H Tsang
    Ophthalmology, Columbia University, New York, NY
  • Janet R Sparrow
    Ophthalmology, Columbia University, New York, NY
  • Footnotes
    Commercial Relationships Tobias Duncker, None; Francois Delori, None; Jonathan Greenberg, None; Winston Lee, None; Jana Zernant, None; Rando Allikmets, None; Stephen Tsang, None; Janet Sparrow, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1417. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tobias Duncker, Francois C Delori, Jonathan P Greenberg, Winston Lee, Jana Zernant, Rando Allikmets, Stephen H Tsang, Janet R Sparrow; Quantitative Fundus Autofluorescence in Bull’s-Eye Maculopathy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1417. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To obtain quantitative fundus autofluorescence (qAF) measurements in patients with Bull’s-Eye maculopathy (BEM) and determine whether qAF can differentiate between ABCA4- and non-ABCA4-related disease in this phenotype that is common to some retinal dystrophies.

Methods: 40 BEM patients (mean age of 32.0 years; range: 8-67 years) were studied. All patients exhibited a well-delineated macular lesion and qualitatively normal appearing surrounding retina without flecks. AF images (30°, 488 nm excitation) were acquired with a confocal scanning laser ophthalmoscope equipped with an internal fluorescent reference to account for variable laser power and detector sensitivity. The gray levels (GLs) of each image were calibrated to the reference, zero GL, magnification, and normative optical media density, to yield qAF. All patients were screened for mutations in the ABCA4 gene with the ABCR700 microarray and/or by next generation sequencing.

Results: At least one ABCA4 mutation was identified in 23 patients, who tended to be younger (mean age: 23.9 years) than ABCA4-negative patients (mean age: 42.9 years). Only 3 ABCA4-positive patients, 2 of which were homozygous for G1916E, did not have qAF levels above the 95% confidence interval of normal controls. Conversely, 15/17 ABCA4-negative patients had qAF levels within the normal range.

Conclusions: The qAF method permits a determination of genotype-phenotype correlations and can help to identify BEM patients that should be considered for ABCA4 screening.

Keywords: 696 retinal degenerations: hereditary • 582 ipofuscin • 550 imaging/image analysis: clinical  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×